WuXi AppTec, WuXi Biologics surge on slimmer chances of US Biosecure Act’s passage
Shares of Chinese biotech service providers WuXi AppTec and WuXi Biologics surged on Monday, after a draft US legislation seeking to eliminate their linchpin role in global drug development missed its last big window for passage into law this year. WuXi AppTec’s shares rose as much as 12 per cent in early trading in Hong […]
WuXi AppTec, WuXi Biologics surge on slimmer chances of US Biosecure Act’s passage Read More »